Nano Therapy: Increasing Demand For The Better Treatment For Diseases Lifts The Market Growth at a CAGR of 8.2% During Forecast Period 2017-2023

Pune, India, August 2017 /MRFR Press Release/- Market Research Future published a half-cooked research report on the global nanotherapy market. 

Market Highlights

Market Scenario

Nanotherapy is an advanced methodology in proper detection and improved diagnosis for the proper treatment of diseases. According to the National Cancer Institute (2014), 14 million people were suffering from cancer worldwide, which is expected to reach 19 million till 2024. The key driving factors for the growth of nanotherapy market are increasing the prevalence of diseases such as diabetes and cancer, rising demand for the better treatment option, and increasing healthcare expenditure. Furthermore, government support for research and continuous improvement in healthcare infrastructure boost the market. However, higher cost of treatment and strict regulatory norms may restrain the growth of the global nanotherapy market. 

The global nanotherapy market is expected to grow at a CAGR of 8.2% during the forecasted period 2017-2023.

Segmentation

The global nanotherapy market is segmented on the basis of technologies, applications, and end users. On the basis of technology the market is segmented: nanomaterial and biological device, nano electronic biosensor, molecular nanotechnology, implantable cardioverter-defibrillators, and others. On the basis of application the market is classified: cardiovascular disease, cancer therapy, diabetes treatment, rheumatoid arthritis and others. On the basis of end users, the market is segmented into hospitals, clinics and research institutions

Figure 1- Global nano therapy market, by application

     Source- Annual reports, press release, white paper, company presentation

Regional Analysis

America dominates the global nanotherapy market owing to increasing prevalence of cancer and other chronic diseases, well-developed healthcare sector, and growing demand for the better treatment. Europe commands as the second largest market, which is followed by Asia Pacific. Well-developed infrastructure, increasing demand for better treatment, and extensive research in nanotechnology sector for new drugs development using nano-medical devices have driven this market in Europe. Asia Pacific is expecting the fastest growth in the market during the forecasted period. Rapid growth in the healthcare sector, developing economies, and increasing need for better treatment for the diseases have encouraged the nano technology market of Asia Pacific region. However, the Middle East & Africa holds the least share in the global market.

Competitive Analysis

 Sources- Annual reports, press release, white paper, company presentation

Some of the key players in the global nanotherapy market: Smith and Nephew (UK), Selecta Biosciences, Inc. (US), Sirnaomics, Inc. (US), Tarveda Therapeutics (US), DIM (US), Cristal Therapeutics (thr Netherland), CytImmune Science, Inc. (US), Luna (US), NanoBio Corporation (US), NanoBioMagnetics.n.nu (US), Nanobiotix (France), Nanoprobes, Inc. (US), Parvus Therapeutics (US), Nanospectra Biosciences, Inc (US), Nanosphere Inc. (US), NanoMedia Solutions Inc. (Japan). 

Many companies are actively engaged in the development of novel products due to increasingly tie ups between nano medicine startups and leading enterprises. Major companies are investing billions in research and development with the help of government support and trying to introduce new devices and therapy in the market, which will grow the market for the nanotherapy in future. Some companies are focusing on acquisitions and strategic alliances for the growth of the market.

Smith and Nephew, headquartered in London, United Kingdom, is a multinational medical equipment manufacturing company. The company is majorly focused on the development of new products and has launched the silver nano crystals (Acticoat), which is antimicrobial wound dressings. 

Parvus Therapeutics, a Canadian healthcare company, is focusing on development for better treatment for autoimmune diseases. The company has launched, nanoparticles designed to fight autoimmune diseases. In April 2017, the company announced its collaboration with Novartis AG for the development of the new drug for the treatment of type 1 diabetes.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/nano-therapy-market-924

About Market Research Future:      

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Solutions, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com